160 related articles for article (PubMed ID: 36516438)
1. Discovery of Novel Acridane-Based Tubulin Polymerization Inhibitors with Anticancer and Potential Immunomodulatory Effects.
Peng X; Ren Y; Pan W; Liu J; Chen J
J Med Chem; 2023 Jan; 66(1):627-640. PubMed ID: 36516438
[TBL] [Abstract][Full Text] [Related]
2. X-ray Crystal Structure-Guided Discovery of Novel Indole Analogues as Colchicine-Binding Site Tubulin Inhibitors with Immune-Potentiating and Antitumor Effects against Melanoma.
Ren Y; Wang Y; Liu J; Liu T; Yuan L; Wu C; Yang Z; Chen J
J Med Chem; 2023 May; 66(10):6697-6714. PubMed ID: 37145846
[TBL] [Abstract][Full Text] [Related]
3. Design, synthesis, and biological evaluation of diaryl heterocyclic derivatives targeting tubulin polymerization with potent anticancer activities.
Li G; Wu JQ; Cai X; Guan W; Zeng Z; Ou Y; Wu X; Li J; Fang X; Liu J; Zhang Y; Wang H; Yin C; Yao H
Eur J Med Chem; 2023 Apr; 252():115284. PubMed ID: 36940610
[TBL] [Abstract][Full Text] [Related]
4. 2-Alkoxycarbonyl-3-arylamino-5-substituted thiophenes as a novel class of antimicrotubule agents: Design, synthesis, cell growth and tubulin polymerization inhibition.
Romagnoli R; Kimatrai Salvador M; Schiaffino Ortega S; Baraldi PG; Oliva P; Baraldi S; Lopez-Cara LC; Brancale A; Ferla S; Hamel E; Balzarini J; Liekens S; Mattiuzzo E; Basso G; Viola G
Eur J Med Chem; 2018 Jan; 143():683-698. PubMed ID: 29220790
[TBL] [Abstract][Full Text] [Related]
5. Discovery of novel CA-4 analogs as dual inhibitors of tubulin polymerization and PD-1/PD-L1 interaction for cancer treatment.
Yang X; Cheng B; Xiao Y; Xue M; Liu T; Cao H; Chen J
Eur J Med Chem; 2021 Mar; 213():113058. PubMed ID: 33280898
[TBL] [Abstract][Full Text] [Related]
6. Discovery of a Novel Vascular Disrupting Agent Inhibiting Tubulin Polymerization and HDACs with Potent Antitumor Effects.
Zhu H; Tan Y; He C; Liu Y; Duan Y; Zhu W; Zheng T; Li D; Xu J; Yang DH; Chen ZS; Xu S
J Med Chem; 2022 Aug; 65(16):11187-11213. PubMed ID: 35926141
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel dihydroquinolin-4(1H)-one derivatives as novel tubulin polymerization inhibitors.
Tan Y; Hu H; Zhu W; Wang T; Gao T; Wang H; Chen J; Xu J; Xu S; Zhu H
Eur J Med Chem; 2023 Dec; 262():115881. PubMed ID: 37883897
[TBL] [Abstract][Full Text] [Related]
8. Discovery of indoline derivatives as anticancer agents via inhibition of tubulin polymerization.
Wang SY; Liu X; Meng LW; Li MM; Li YR; Yu GX; Song J; Zhang HY; Chen P; Zhang SY; Hu T
Bioorg Med Chem Lett; 2021 Jul; 43():128095. PubMed ID: 33965530
[TBL] [Abstract][Full Text] [Related]
9. Discovery of Novel
Leng J; Zhao Y; Sheng P; Xia Y; Chen T; Zhao S; Xie S; Yan X; Wang X; Yin Y; Kong L
J Med Chem; 2022 Dec; 65(24):16774-16800. PubMed ID: 36471625
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis, and bioevaluation of pyrazolo[1,5-a]pyrimidine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site with potent anticancer activities.
Li G; Wang Y; Li L; Ren Y; Deng X; Liu J; Wang W; Luo M; Liu S; Chen J
Eur J Med Chem; 2020 Sep; 202():112519. PubMed ID: 32650183
[TBL] [Abstract][Full Text] [Related]
11. Discovery of novel coumarin-indole derivatives as tubulin polymerization inhibitors with potent anti-gastric cancer activities.
Song J; Guan YF; Liu WB; Song CH; Tian XY; Zhu T; Fu XJ; Qi YQ; Zhang SY
Eur J Med Chem; 2022 Aug; 238():114467. PubMed ID: 35605363
[TBL] [Abstract][Full Text] [Related]
12. Design, synthesis, and biological evaluation of novel benzodiazepine derivatives as anticancer agents through inhibition of tubulin polymerization in vitro and in vivo.
Pang Y; Lin H; Ou C; Cao Y; An B; Yan J; Li X
Eur J Med Chem; 2019 Nov; 182():111670. PubMed ID: 31499359
[TBL] [Abstract][Full Text] [Related]
13. Discovery of N-benzylarylamide derivatives as novel tubulin polymerization inhibitors capable of activating the Hippo pathway.
Song J; Wang SH; Song CH; Zhang WX; Zhu JX; Tian XY; Fu XJ; Xu Y; Jin CY; Zhang SY
Eur J Med Chem; 2022 Oct; 240():114583. PubMed ID: 35834904
[TBL] [Abstract][Full Text] [Related]
14. Discovery of novel coumarin-based derivatives as inhibitors of tubulin polymerization targeting the colchicine binding site with potent anti-gastric cancer activities.
Tian XY; Zhang WX; Chen XY; Jia MQ; Zhang SY; Chen YF; Yuan S; Song J; Li J
Eur J Med Chem; 2024 Feb; 265():116079. PubMed ID: 38150962
[TBL] [Abstract][Full Text] [Related]
15. Discovery of a novel Coumarin-Dihydroquinoxalone derivative MY-673 as a tubulin polymerization inhibitor capable of inhibiting the ERK pathway with potent anti-gastric cancer activities.
Song J; Wang SY; Wang X; Jia MQ; Tian XY; Fu XJ; Jin CY; Zhang SY
Bioorg Chem; 2023 Aug; 137():106580. PubMed ID: 37149948
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and evaluation of novel bis-substituted aromatic amide dithiocarbamate derivatives as colchicine site tubulin polymerization inhibitors with potent anticancer activities.
Sun YX; Song J; Kong LJ; Sha BB; Tian XY; Liu XJ; Hu T; Chen P; Zhang SY
Eur J Med Chem; 2022 Feb; 229():114069. PubMed ID: 34971875
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel benzo[c]acridine-diones as potential anticancer agents and tubulin polymerization inhibitors.
Behbahani FS; Tabeshpour J; Mirzaei S; Golmakaniyoon S; Tayarani-Najaran Z; Ghasemi A; Ghodsi R
Arch Pharm (Weinheim); 2019 Jun; 352(6):e1800307. PubMed ID: 31012156
[TBL] [Abstract][Full Text] [Related]
18. Discovery of novel N-benzylbenzamide derivatives as tubulin polymerization inhibitors with potent antitumor activities.
Zhu H; Li W; Shuai W; Liu Y; Yang L; Tan Y; Zheng T; Yao H; Xu J; Zhu Z; Yang DH; Chen ZS; Xu S
Eur J Med Chem; 2021 Apr; 216():113316. PubMed ID: 33676300
[TBL] [Abstract][Full Text] [Related]
19. Rational design, synthesis and biological evaluation of novel 2-(substituted amino)-[1,2,4]triazolo[1,5-a]pyrimidines as novel tubulin polymerization inhibitors.
Chen L; Ji TY; Huo XS; Zeng ZY; Ye WX; Dai CC; Zhang YQ; You WW; Zhao PL
Eur J Med Chem; 2022 Dec; 244():114864. PubMed ID: 36334455
[TBL] [Abstract][Full Text] [Related]
20. Discovery and optimization of 3,4,5-trimethoxyphenyl substituted triazolylthioacetamides as potent tubulin polymerization inhibitors.
Yang F; He CP; Diao PC; Hong KH; Rao JJ; Zhao PL
Bioorg Med Chem Lett; 2019 Jan; 29(1):22-27. PubMed ID: 30448234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
